8-K
filed March 19, 2026, 7:59 PM ET
ticker PTHS
CIK 0001919246
earnings
confidence high
sentiment positive
materiality 0.75
Pelthos Q4 ZELSUVMI sales $9.1M, up 28% QoQ; adds XEPI and XEGLYZE
Pelthos Therapeutics Inc.
- ZELSUVMI net product revenue $9.1M in Q4 2025 vs $7.1M in Q3; full-year 2025 total revenue $16.8M.
- 8,948 units dispensed, 2,712 unique prescribers; Q4 units up 129% QoQ to 6,232.
- Acquired XEPI (impetigo) Nov 2025 and XEGLYZE (head lice) Jan 2026; sales force expanded to 64.
- Closed $18M convertible notes Nov 2025 and $50M term loan ($30M drawn) Jan 2026; cash $18M at year-end.
- Operating loss improved to $12M in Q4 from $15.4M in Q3; adjusted EBITDA loss improved 22% QoQ.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001919246-26-000014
- form_type
- 8-K
- ticker
- PTHS
- cik
- 0001919246
- company_name
- Pelthos Therapeutics Inc.
- filed_at
- 2026-03-19T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.756905+00:00
- generated_at
- 2026-05-15T09:42:34.139412+00:00
- sec_items
- ["2.02", "7.01", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001919246-26-000014
- json_url
- https://secwatch.observer/filing/0001919246-26-000014.json
- markdown_url
- https://secwatch.observer/filing/0001919246-26-000014.md
- text_url
- https://secwatch.observer/filing/0001919246-26-000014.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1919246/000191924626000014/0001919246-26-000014-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1919246/000191924626000014/pths-20260319.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
FNGR
FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M
FingerMotion, Inc.
May 29, 2026, 5:12 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
ADSK
Autodesk Q1 FY27 revenue up 18% to $1.93B, GAAP EPS $2.32; acquires MaintainX
Autodesk, Inc.
May 28, 2026, 4:14 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
OKTA
Okta Q1 FY2027 rev $765M (+11% YoY); GAAP net income $74M; free cash flow $271M
Okta, Inc.
May 28, 2026, 4:03 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SOTK
Sono-Tek reports FY2026 net income up 42% to $1.8M; gross margin expands to 51%
SONO TEK CORP
May 28, 2026, 7:10 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DLTR
Dollar Tree Q1 net sales +7.2%, comp +3.5%, adj EPS $1.74 (+38%), raises FY guidance
DOLLAR TREE, INC.
May 28, 2026, 6:31 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
BBWI
BBWI Q1 sales down 3%, adjusted EPS $0.32 beats guidance; CFO Boratto to step down June 12
Bath & Body Works, Inc.
May 27, 2026, 7:12 AM ET
earnings
Items 2.02, 7.01, 5.02, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SMTC
Semtech reports record Q1 net sales $291M, GAAP EPS $0.27, adjusted EPS $0.51
SEMTECH CORP
May 26, 2026, 4:07 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
EMAT
EMAT reports Q1 GAAP net loss of $440.3M on $425M non-cash charge; adjusted loss $15.1M
Evolution Metals & Technologies Corp.
May 22, 2026, 9:28 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.